Overview

A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
To compare the gastroprotective effects of a once-daily dose of PA 325 combination tablet
Phase:
Phase 1
Details
Lead Sponsor:
POZEN
Treatments:
Aspirin
Omeprazole